Voyager Therapeutics (VYGR) Cash from Investing Activities Growth (1y) (2015 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Cash from Investing Activities Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | -1,435.24% |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -634.97% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 27.49% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -389.88% |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 68.76% |
| 10 | Voyager Therapeutics | 195.27 Mn | 78.93 Mn | - | 696.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 696.22% |
| Mar 31, 2026 | -80.34% |
| Dec 31, 2025 | 274.33% |
| Sep 30, 2025 | -45.79% |
| Jun 30, 2025 | 105.38% |
| Mar 31, 2025 | 142.89% |
| Dec 31, 2024 | -201.38% |
| Sep 30, 2024 | 140.65% |
| Jun 30, 2024 | -45.74% |
| Mar 31, 2024 | -762.93% |
| Dec 31, 2023 | 90.75% |
| Sep 30, 2023 | -555.92% |
| Jun 30, 2023 | 31.74% |
| Mar 31, 2023 | 172.46% |
| Dec 31, 2022 | 357.45% |
| Sep 30, 2022 | 142.13% |
| Jun 30, 2022 | -261.26% |
| Mar 31, 2022 | -157.76% |
| Dec 31, 2021 | 74.60% |
| Sep 30, 2021 | -47.58% |